Clinical Trial: Special Survey for Long Term Application
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application
Brief Summary: This study is conducted in Japan. The aim of this study is to assess the incidence rate of adverse drug reactions (ADRs) when using somatropin (Norditropin®) for treatment of for achondroplasia without epiphyseal line closure under normal clinical practice conditions.
Detailed Summary:
Sponsor: Novo Nordisk A/S
Current Primary Outcome: Incidence of adverse drug reactions (ADRs)
Original Primary Outcome: Same as current
Current Secondary Outcome: Treatment evaluation using the Foundation for Growth Science's Criteria for Treatment Continuation: Definitely effective, effective, ineffective or definitely ineffective
Original Secondary Outcome: Same as current
Information By: Novo Nordisk A/S
Dates:
Date Received: January 19, 2012
Date Started: May 1, 1997
Date Completion:
Last Updated: February 23, 2017
Last Verified: February 2017